CNMD Financial Facts
Gross profit: 101.21MResearch and development expense: 8.35M
See Full Income Statement
Deferred income taxes: 119.02M
Accounts payable.: 36.7M
See Full Balance Sheet
CONMED Corporation (CNMD) Earnings
|
Expand Research on CNMD
| Next EPS Date | 10/28/26 | EPS Growth Rate | -7.4% |
|---|---|---|---|
| Average EPS % Beat Rate | +11.0% | Revenue Growth Rate | -0.9% |
| Average % Move 1-Wk after EPS | +5.3% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
10/28/26  |
Q326 | N/A | $1.00 | N/A | N/A | $334.93M | = | N/A | N/A | ||
| 7/29/26 | Q226 | $1.38 | $1.11 | +$0.27 | $343.5M | $337.46M | = |  | | Details | |
| 4/29/26 | Q126 | $0.89 | $0.82 | +$0.07 | $317M | $310.59M | = | | | Details | |
| 1/28/26 | Q425 | $1.43 | $1.32 | +$0.11 | $373.2M | $366.97M | = | | | Details | |
| 11/5/25 | Q325 | $1.08 | $1.05 | +$0.03 | $337.9M | $334.71M | = | | | Details | |
| 7/30/25 | Q225 | $1.15 | $1.12 | +$0.03 | $342.34M | $338.4M | = | | | Details | |
| 4/30/25 | Q125 | $0.95 | $1.00 | -$0.05 | $321.3M | $332.91M | = | | | Details | |
| 2/5/25 | Q424 | $1.34 | $1.21 | +$0.13 | $345.9M | $341M | = | | | Details |
